Olanzapine long-acting inj
Products billed under this code include Zyprexa Relprevv.
Payment limit per 1 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Zyprexa Relprevv.
Payment limit per 1 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Zyprexa Relprevv | Eli Lilly and Company | 00002-7637-11 | 405 | $1,296.81 |
| Zyprexa Relprevv | H2 Pharma LLC | 61269-0660-20 | 210 | $672.42 |
| Zyprexa Relprevv | H2 Pharma LLC | 61269-0661-20 | 300 | $960.60 |
| Zyprexa Relprevv | H2 Pharma LLC | 61269-0662-20 | 405 | $1,296.81 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $3.202 | +$0.003 | 1 MG | Olanzapine long-acting inj | v1, posted September 17, 2026 |
| 3Q26 | $3.199 | +$0.013 | 1 MG | Olanzapine long-acting inj | v1, posted September 15, 2026 |
| 2Q26 | $3.186 | +$0.028 | 1 MG | Olanzapine long-acting inj | v1, posted September 15, 2026 |
| 1Q26 | $3.158 | +$0.241 | 1 MG | Olanzapine long-acting inj | v1, posted September 15, 2026 |
| 4Q25 | $2.917 | $0.00 | 1 MG | Olanzapine long-acting inj | v1, posted September 8, 2026 |
| 3Q25 | $2.917 | $0.00 | 1 MG | Olanzapine long-acting inj | v1, posted March 10, 2026 |
| 2Q25 | $2.917 | $0.00 | 1 MG | Olanzapine long-acting inj | v1, posted March 10, 2026 |
| 1Q25 | $2.917 | $0.00 | 1 MG | Olanzapine long-acting inj | v1, posted December 19, 2025 |
| 4Q24 | $2.917 | $0.00 | 1 MG | Olanzapine long-acting inj | v1, posted June 11, 2025 |
| 3Q24 | $2.917 | $0.00 | 1 MG | Olanzapine long-acting inj | v1, posted June 11, 2025 |
| 2Q24 | $2.917 | $0.00 | 1 MG | Olanzapine long-acting inj | v1, posted March 11, 2025 |
| 1Q24 | $2.917 | $0.00 | 1 MG | Olanzapine long-acting inj | v1, posted December 19, 2024 |
| 4Q23 | $2.917 | $0.00 | 1 MG | Olanzapine long-acting inj | v1, posted October 10, 2024 |
| 3Q23 | $2.917 | $0.00 | 1 MG | Olanzapine long-acting inj | v1, posted June 5, 2024 |
| 2Q23 | $2.917 | $0.00 | 1 MG | Olanzapine long-acting inj | v1, posted February 23, 2024 |
| 1Q23 | $2.917 | $0.00 | 1 MG | Olanzapine long-acting inj | v1, posted December 6, 2023 |
| 4Q22 | $2.917 | +$0.003 | 1 MG | Olanzapine long-acting inj | v1, posted June 22, 2023 |
| 3Q22 | $2.914 | −$0.006 | 1 MG | Olanzapine long-acting inj | v1, posted June 9, 2023 |
| 2Q22 | $2.92 | +$0.003 | 1 MG | Olanzapine long-acting inj | v1, posted December 14, 2022 |
| 1Q22 | $2.917 | +$0.003 | 1 MG | Olanzapine long-acting inj | v1, posted June 8, 2022 |
| 4Q21 | $2.914 | −$0.003 | 1 MG | Olanzapine long-acting inj | v1, posted June 2, 2022 |
| 3Q21 | $2.917 | $0.00 | 1 MG | Olanzapine long-acting inj | v1, posted June 2, 2022 |
| 2Q21 | $2.917 | $0.00 | 1 MG | Olanzapine long-acting inj | v1, posted March 1, 2022 |
| 1Q21 | $2.917 | – | 1 MG | Olanzapine long-acting inj | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.